European Pharmaceutical Manufacturer is a highly regarded publication that covers the pharma/biopharma manufacturing supply chain from formulation to distribution, sharing the latest updates, perspectives, developments, and breakthroughs in this innovative, high-tech field. The bi-monthly magazine reaches over 18,000 readers, including decision-makers and thought leaders in the European pharmaceutical manufacturing sector.
This article examines the global market for connected drug delivery devices. Specifically, the market for injectables and inhalation devices is projected to reach $706 million by 2025 – representing a compound annual growth rate (CAGR) of more than 25% from its $225 million size in 2020. That level of growth, though, will depend on the actions and attitudes of key industry stakeholders.
Healthcare systems can benefit greatly from the efficiency of connected drug delivery devices, and the expansion of this sector is inevitable – but the success and scale of their implementation relies on effective collaboration across parties.
Read more from our Head of Product Strategy and Insights, George I’ons.